Grid Exponential

SphereBio, established in 2023, specializes in developing biotechnology platforms that facilitate the delivery of molecules to cells, thereby training them to respond to specific health issues. The company leverages its platforms to provide pharmaceutical and veterinary businesses with innovative methods to enhance vaccines and therapeutics, tailored to combat diseases like cancer.

MicroIN is a biotechnology company that specializes in enhancing the stability and effectiveness of biological products, particularly in the agro-environmental sector. It achieves this by developing customized encapsulation protocols for microorganisms, improving their viability and optimizing bioinput formulations.

GlycoX is a biotechnology company specializing in innovative diabetes management solutions. It develops an oral solution aimed at controlling blood sugar levels, empowering diabetic patients and improving their quality of life. The company's approach combines natural elements with advanced technology, aiming to revolutionize diabetes treatment.

Invitrall is a biotechnology company that specializes in creating advanced, human-like disease models in vitro. By leveraging genomic technology, they develop models that represent human genetic diversity, bridging the gap left by traditional animal or cell-based models. This enables Invitrall to provide innovative solutions for testing the safety and efficacy of pharmaceutical and cosmetic products, ultimately accelerating the development of therapies for various diseases.

Scitherm is a startup that dedicates to validating treatments for the control of overweight and obesity.

BioBlends develops biopreservatives for the food industry to extend the shelf life of food products.

Polymera leverages the adaptive mechanisms of an extremophile antarctic bacterium to develop naturally biodegradable biopolymers.

Protiva Bioinks is a biotech startup that produces low-cost and eco-friendly dyes for textile industrial production. It offers a wide range of natural colorants derived from microorganisms that are cost-effective, sustainable, and can replace synthetic dyes. Protiva's mission is to transform dyeing in the textile industry, creating a more sustainable future. Its headquarters is located in Comuna 1, Buenos Aires Autonomous City.

MIGMA uses Artificial Intelligence to accelerate the discovery of new synergistic combinations of antioxidants.

Biodiversity Intelligence is a technology company that specializes in environmental monitoring. It has developed a comprehensive system that combines environmental metagenomics, satellite-based monitoring, climate data, and environmental chemistry to track and analyze biodiversity. This integrated platform enables the company to monitor biodiversity effectively, engage a wide network of scientists for data validation, and even facilitate the discovery of new species. By offering a more cost-effective and efficient monitoring methodology, Biodiversity Intelligence caters to clients seeking robust, up-to-date information on environmental biodiversity.

CyanoMin harnesses cyanobacteria to make carbon-negative minerals without mining, reducing the net carbon footprint of the products.

Apasomics is a biotechnology company specializing in bone-targeted drug delivery. It develops apasome-based nanocarriers to deliver bisphosphonates directly to bones, enhancing treatment efficacy for osteoporosis and other skeletal disorders while minimizing side effects. By combining nanotechnology and precision medicine, Apasomics aims to improve therapeutic outcomes and patient quality of life.

Monte Caldera Technologies is a science-driven company that applies fundamental physics to develop innovative solutions for various industries. It offers a scientific technology platform that accelerates materials discovery through advanced, physics-based molecular modeling. This platform provides real-time molecular insights and optimization capabilities, helping industries such as chemicals, biotech, energy, and semiconductors enhance their research and development processes, improve sustainability, and reduce waste. Additionally, Monte Caldera provides consulting and molecular-level simulation services tailored to diverse industries.

Nanoingreen is a green synthesis company focused on transforming plant-based products into functional foods through precision fermentation processes. The company develops specific formulations that enhance the nutritional profile and functionality of food products, enabling clients to create next-generation offerings with unique flavors and textures. By incorporating these formulations, Nanoingreen aims to address future health challenges and improve the overall quality of plant-based foods, positioning itself as a leader in the functional food market.

Elytron is a biotechnology company focused on developing bio-pesticides that enhance crop growth while eliminating the need for chemical inputs. By leveraging advanced biotechnology and bioinformatics, Elytron creates innovative solutions for pest and disease management, enabling farmers to improve their yields sustainably. Additionally, the company utilizes artificial intelligence to streamline research and development processes for biocontrol inputs, allowing for the rapid screening of microorganisms and their potential applications across various biology-based industries. This approach aims to transform traditional methods into more efficient digital processes, ultimately addressing significant agricultural challenges and promoting environmentally friendly practices.

Bioplastix is a pioneering company transforming the plastics industry by developing sustainable materials. It uses proprietary technology, involving genetically modified E. coli, to produce advanced bioplastics like PLA and PHB from renewable sources. The company employs artificial intelligence to optimize its strains and bioprocesses, ensuring high efficiency and scalability. Bioplastix aims to create the world's leading bioplastics formulation and production platform, offering superior performance at competitive prices, and thereby setting a new standard for sustainability in the industry.

APEXzymes focuses on developing microbial technologies for industrial production of biofertilizers and enzymes. It builds enzyme production platforms using genetic engineering and fermentation to create high-performance enzymes at lower cost, and provides advanced enzyme formulations optimized for cost-efficiency and scalability. These offerings support biofuel production and animal nutrition by improving sustainability and reducing expenses, while increasing operational viability.

CellRep is a biotechnology company specializing in the development of cell reprogramming strategies. Its primary focus is to enhance the functionality of immune cells, thereby improving the overall efficacy of cell therapies. The company provides services including target and drug discovery, in vitro screening, and preclinical testing, helping clients explore novel approaches to T-cell functionality.

We use insects to process organic waste in modular units called bioreactors and offer this technology as a waste management service. This modular infrastructure allows us to integrate our units into the existing waste infrastructure of our clients and, at their facilities, convert their waste into high-value and low-impact protein, fertilizer and, because we have a carbon negative process, carbon bonds.

Invitrall is a biotechnology company that specializes in creating advanced, human-like disease models in vitro. By leveraging genomic technology, they develop models that represent human genetic diversity, bridging the gap left by traditional animal or cell-based models. This enables Invitrall to provide innovative solutions for testing the safety and efficacy of pharmaceutical and cosmetic products, ultimately accelerating the development of therapies for various diseases.

Sylvarum is an innovative biotech startup focused on plant electrostimulation technology designed to enhance crop metabolism. By employing external electric and magnetic fields, the company aims to improve the natural metabolic processes of plants. This approach leads to better germination rates, accelerated growth, and increased ion uptake capacity, resulting in significant yield improvements for agricultural producers. Sylvarum's technology represents a transformative solution for the agricultural sector, enabling sustainable and efficient crop production.

PunaBio is a company based in Buenos Aires, Argentina, that specializes in developing biological products for the agricultural sector. Their focus is on enhancing crop nutrition through the use of extremophile microorganisms. These products are designed to boost yields, improve crop quality, and enable farming on degraded soils. By utilizing sustainable biological solutions, PunaBio aims to help farmers increase productivity and production while promoting environmentally friendly practices.

Bioeutectics is a company focused on enhancing the sustainability of industrial processes by providing high-performance, natural solvents. Utilizing proprietary eutectic technology, Bioeutectics mimics the natural solvent production methods of plants and relies on 100% renewable resources. This innovative approach enables the company to replace traditional petrochemical solvents with eco-friendly alternatives in various industries, including food, pharmaceuticals, and personal care. The solvents produced are non-toxic, biodegradable, and customizable, allowing for tailored solutions that meet specific industry needs while promoting environmental responsibility. Through its commitment to sustainable practices, Bioeutectics positions itself as a leader in the production of green solvents, contributing to a more sustainable future.

Dogma BioTech is a biotechnology firm that develops protein-based therapeutics.

Alkemio, headquartered in Buenos Aires, specializes in developing sustainable separation and purification technologies for rare earth elements (REEs) and critical metals. The company offers mining and recycling industries a cost-effective, eco-friendly alternative to conventional methods, enhancing REE recovery and reducing waste, energy consumption, and refining steps. Alkemio's innovative Molecular Adsorption Technology and bio-magnetic processes enable efficient separation and purification of REEs and critical metals from various waste streams, including electronic waste.

Nunatak Biotech operates a biotechnology company focused on enhancing plant growth in harsh conditions and restoring degraded soils. It develops biological systems that aid plant growth in challenging environments, such as drought or nutrient-depleted soils, and harnesses natural processes to restore ecosystems. This enables increased agricultural productivity and contributes to sustainable food production.

AlgaLife is a biotechnology company that focuses on improving microalgae cultivation processes, enabling 95% cheaper production costs while maintaining high yields. The company's core product is a microalgae consortium designed to enhance aquaculture efficiency and sustainability. This consortium improves gut health and immunological activity in farmed aquatic animals, reducing mortality rates and enabling the aquaculture industry to meet sustainability challenges more effectively.

Ocular Bio Design is a tissue engineering company for the regeneration of visual function.

Restoring crops' ability to defend against pests.

Smart delivery biocapsules that enhance crop production.

Qnity leverages quantum electrochemical principles to develop tools for drug discovery and other product innovations.

Naturannova is a company focused on advancing food technology through the discovery and development of plant-based protein flavors and ingredients. By integrating computational biology with biomanufacturing processes, Naturannova aims to create innovative and sustainable food solutions. Its computational platform is designed to identify proteins from plant sources, enabling food and beverage manufacturers to streamline their development processes. This approach not only reduces time and costs but also supports healthier consumer choices by providing access to next-generation ingredients that promote well-being.

Aquit is a biotechnology company specializing in the development of preventive treatments for fish infections. Their innovative solutions aim to replace antibiotics, thereby enhancing fish immunity, improving survival rates, and promoting sustainable aquaculture practices.

Gisens Biotech is a biotechnology company focused on bioelectronics and nanotechnology, developing portable diagnostics such as the Nano-Lab, a device that provides real-time measurements of biomarkers from tiny samples of blood, urine, or saliva. The Nano-Lab aims to deliver accurate, portable biomarker analysis and interpretation, potentially changing how measurements are performed. The company is also pursuing a nanotechnology-based platform to diagnose and monitor renal biomarkers—urea, creatinine, and potassium—from a single blood drop, with results accessible through an application for real-time health monitoring.

Embryoxite is a biotechnology company specializing in non-invasive diagnostic services for pre-implantation embryos in human-assisted reproduction. It operates a platform that combines artificial intelligence, metabolomics, embryo imaging, and clinical data to enhance embryo selection accuracy and improve patient outcomes for fertility clinics and reproductive specialists.

Eywa is a biotechnology company specializing in the development of innovative production methods for psychedelic medicines. It focuses on designing efficient processes and products to enhance the adoption of these treatments, leveraging biosynthesis to create patient-centered therapies aimed at improving mental health outcomes.

Fungi Life is a biotech company specializing in the innovative production of biosurfactants derived from fungal biotechnology. By utilizing fungi, the firm develops sustainable alternatives to synthetic surfactants and enzymes, aiming to replace harmful petroleum-based ingredients across various industries, including oil and gas, cleaning, cosmetics, agriculture, and personal care. Fungi Life's approach focuses on enhancing product biodegradability and reducing environmental impact, positioning the company as a leader in promoting eco-friendly solutions within the biotechnology sector.

Corporation - SAU

Ubique Bio is a biotechnology company that has a dedication to make diagnostics available for everyone, everywhere.

Qumir Nano is a pioneering company that develops and supplies eco-friendly nanoparticles for sustainable agriculture. Utilizing a proprietary bio-nanotechnology platform, the company produces these particles through a green synthesis method that employs microorganisms sourced from jungles. Qumir Nano's products offer nutritional and antimicrobial properties, helping farmers enhance crop health while minimizing pesticide pollution.

Future Biome is a biotechnology company focused on enhancing health through innovative microbiome solutions. The company specializes in developing precision fungi-based prebiotics aimed at improving gut health. Utilizing a predictive bioinformatics platform, Future Biome customizes prebiotic formulations to suit individual microbiota profiles or specific market segments, aiming for increased efficacy and predictable outcomes. Their initial product, a fungal prebiotic, has demonstrated significant improvements in microbiota function in laboratory studies, showing up to 500% enhancement with complete efficacy compared to existing market benchmarks. Future Biome plans to initiate clinical trials for this groundbreaking prebiotic in April 2024, marking a significant step towards personalized gut health interventions.

PunaBio is a company based in Buenos Aires, Argentina, that specializes in developing biological products for the agricultural sector. Their focus is on enhancing crop nutrition through the use of extremophile microorganisms. These products are designed to boost yields, improve crop quality, and enable farming on degraded soils. By utilizing sustainable biological solutions, PunaBio aims to help farmers increase productivity and production while promoting environmentally friendly practices.

Updairy is a company that produces food ingredients, specifically animal-free dairy proteins. It uses microorganisms to create these proteins, replicating the taste and nutritional value of traditional dairy products while significantly reducing greenhouse gas emissions. This allows customers to develop new dairy products with a lower environmental impact than traditional dairy farming.

Stämm Biotech is a San Francisco-based company specializing in advanced bioproduction systems designed to address the scaling challenges in the biotech industry. Founded in 2014, Stämm has developed an innovative biomanufacturing solution that integrates microfluidics, electroporation, and robotics, resulting in a compact, all-in-one Bioprocessor. This system has demonstrated productivity levels at least 70 times greater than traditional bioreactors, enabling clients to miniaturize bioreactors and optimize conditions more efficiently. Stämm's technology incorporates various sensors to monitor biological, physical, and chemical variations throughout the bioprocess, facilitating a streamlined approach to microbial growth and monoclonal cell line development. By transforming large-scale biotech operations into a more manageable micro-factory network, Stämm aims to unlock significant market potential in the coming years.

Nat4Bio develops natural edible coatings that protect fresh produce from spoilage and decay by leveraging microbial fermentation of selected fungi and bacteria to create cell-free compounds. The coatings are odorless and tasteless, edible, and designed to delay ripening and inhibit pathogens while remaining compatible with standard packing systems. The company's first product is an edible coating for lemons that could replace conventional waxes and chemical fungicides, with prototypes in development for blueberries and avocados and plans to expand its portfolio to other fruit classes. By delivering natural, microbe-derived active principles without the microbes themselves, Nat4Bio aims to reduce spoilage and reliance on synthetic chemicals in produce supply chains.

New Organs develops genetically modified pigs to satisfy unmet organ demand through xenotransplantation.

BreakPET is a biotechnology company focused on transforming the recycling of plastic, specifically polyethylene terephthalate (PET) bottles, through innovative enzyme design. The company's platform integrates into the supply chain of the PET recycling industry, enhancing the production and sales of enzymes used in recycling processes. By developing a solution that allows for the simultaneous recycling of all consumed PET bottles, BreakPET aims to improve efficiency and sustainability in plastic waste management. Through its advancements in biotechnology, BreakPET is positioned to play a significant role in addressing the challenges of plastic recycling.

Zavia Bio is a biotechnology startup dedicated to creating innovative bio-solutions for the agricultural sector. The company specializes in developing advanced molecules designed to enhance crop resilience in the face of various adversities, including challenging climatic and environmental conditions. By leveraging scientific and technological advancements, Zavia Bio aims to promote efficient and sustainable agricultural practices. Their solutions enable farmers to produce more food while utilizing less land and water, ultimately contributing to a more sustainable and secure agricultural system.

Microgenesis is a biotechnology company focused on fertility and pregnancy health monitoring. It has developed a platform that provides a non-invasive fertility test and personalized nutritional supplementation aimed at restoring women's fertility potential. The company's innovative diagnostic approach detects subclinical inflammation that negatively impacts ovarian function and implantation, specifically targeting women who have experienced challenges, including multiple failed IVF attempts. Operating out of a CLIA lab in Oakland, Microgenesis offers its solutions through OB-GYNs and direct-to-consumer channels. Additionally, the platform addresses imbalances in vaginal and intestinal microbiota linked to infertility and offers dual testing for immunological issues related to the endometrium, equipping patients with effective treatment options for complex reproductive health cases.

Kresko RNAtech is a biotechnology company focused on the development and production of nutraceuticals. It specializes in identifying bioactive ribonucleic acids (RNAs) from natural sources, utilizing advanced techniques such as machine learning and bioinformatics. By discovering RNAs that may offer health benefits, Kresko RNAtech aims to assist researchers in enhancing human well-being and addressing the challenges posed by stressful and changing environments through innovative RNA technologies.

Syocin Biotech is an Argentina-based company dedicated to advancing agricultural biotechnology through a synthetic biology platform. The company specializes in redesigning natural biomolecules to create precision bactericidal proteins aimed at targeting plant bacterial pathogens that jeopardize global food security. By developing innovative biobactericides, Syocin Biotech enables efficient and sustainable solutions for combating crop pathogens, contributing to enhanced agricultural productivity and food availability.

Nanotransfer specializes in the development of advanced delivery systems utilizing inorganic nanoparticles for gene therapy applications. These systems offer several advantages, including readiness for immediate use by clients, versatility in transporting various types of nucleic acids, and biosafety characteristics, such as non-immunogenicity, allowing for broad patient eligibility and potential re-administration. The delivery systems are designed for high levels of cellular internalization and can be tailored for specificity towards particular cell types, facilitating customized therapies. Furthermore, they possess chemical affinities for the phosphate backbone of nucleic acids, which enhances their ability to integrate genes irrespective of sequence. This approach enables the decoupling of synthesis for the delivery system and the gene of interest, promoting the development of a wider range of therapies aimed at improving health outcomes. Notably, Nanotransfer's non-viral delivery systems can evade endosomal entrapment and resist enzymatic degradation due to their unique composition and surface properties.

OncoPrecision is a biotechnology company focused on enhancing cancer treatment through its innovative patient micro avatar platform. This platform utilizes single-cell high-throughput biology and advanced machine learning techniques to develop comprehensive patient-derived phenotypic biomarkers. By tailoring cancer therapies to individual patients, OncoPrecision aims to significantly increase the success rates of treatments. The company's approach enables oncologists to make informed, data-driven decisions regarding therapy selection based on unique patient samples, thereby improving outcomes in cancer care.

Tomorrow Foods is a company based in Pergamino, Argentina, specializing in the development and production of plant-based ingredients and additives for the food industry. Its offerings include solutions for various applications such as sports nutrition, meat extenders, pasta, dressings, soups, sauces, snacks, cereals, functional beverages, dairy substitutes, and baked goods. By providing integrated turnkey solutions, Tomorrow Foods enables clients to launch nutritious and sustainable products efficiently. The company focuses on introducing innovative alternatives that promote a diverse and well-rounded diet, aligning with the growing consumer demand for healthier food options. Through its research and development efforts, Tomorrow Foods aims to contribute to the evolution of food towards more sustainable practices.

Microgenesis is a biotechnology company focused on fertility and pregnancy health monitoring. It has developed a platform that provides a non-invasive fertility test and personalized nutritional supplementation aimed at restoring women's fertility potential. The company's innovative diagnostic approach detects subclinical inflammation that negatively impacts ovarian function and implantation, specifically targeting women who have experienced challenges, including multiple failed IVF attempts. Operating out of a CLIA lab in Oakland, Microgenesis offers its solutions through OB-GYNs and direct-to-consumer channels. Additionally, the platform addresses imbalances in vaginal and intestinal microbiota linked to infertility and offers dual testing for immunological issues related to the endometrium, equipping patients with effective treatment options for complex reproductive health cases.

Beeflow S.A., founded in 2016 and based in Buenos Aires, Argentina, specializes in professional pollination services that leverage scientific knowledge and technology to enhance bee health and efficiency. The company develops organic compounds that improve the immune systems of bees and train them to pollinate specific crops, such as blueberries, almonds, raspberries, and kiwifruit. By providing these specialized pollination services, Beeflow enables farmers to significantly increase crop yields, with reported improvements ranging from 20% to 90%, while simultaneously addressing the decline in bee populations. Through its innovative approach, Beeflow aims to support agricultural productivity and ecosystem sustainability.

Microgenesis is a biotechnology company focused on fertility and pregnancy health monitoring. It has developed a platform that provides a non-invasive fertility test and personalized nutritional supplementation aimed at restoring women's fertility potential. The company's innovative diagnostic approach detects subclinical inflammation that negatively impacts ovarian function and implantation, specifically targeting women who have experienced challenges, including multiple failed IVF attempts. Operating out of a CLIA lab in Oakland, Microgenesis offers its solutions through OB-GYNs and direct-to-consumer channels. Additionally, the platform addresses imbalances in vaginal and intestinal microbiota linked to infertility and offers dual testing for immunological issues related to the endometrium, equipping patients with effective treatment options for complex reproductive health cases.

Nanogrow Biotech is a manufacturer of nano antibiotics with the goal of developing novel applications in the pharmaceutical industry, particularly for the treatment of skin diseases.

PunaBio is a company based in Buenos Aires, Argentina, that specializes in developing biological products for the agricultural sector. Their focus is on enhancing crop nutrition through the use of extremophile microorganisms. These products are designed to boost yields, improve crop quality, and enable farming on degraded soils. By utilizing sustainable biological solutions, PunaBio aims to help farmers increase productivity and production while promoting environmentally friendly practices.

Cryosmetics is a company dedicated to advancing the future of cosmetics through the development of innovative skincare products. The firm focuses on skincare technology that emphasizes the importance of the skin microbiome, leveraging a blend of technology, science, and biology. Cryosmetics creates products using natural raw materials, ensuring that they are free from preservatives and synthetic chemicals. This commitment enables customers to enhance their well-being while promoting diversity in the skin microbiome.

OncoPrecision is a biotechnology company focused on enhancing cancer treatment through its innovative patient micro avatar platform. This platform utilizes single-cell high-throughput biology and advanced machine learning techniques to develop comprehensive patient-derived phenotypic biomarkers. By tailoring cancer therapies to individual patients, OncoPrecision aims to significantly increase the success rates of treatments. The company's approach enables oncologists to make informed, data-driven decisions regarding therapy selection based on unique patient samples, thereby improving outcomes in cancer care.

ArgenTAG is a biotechnology startup focused on revolutionizing genomic sequencing applications through proprietary technology. The company has developed a reliable and robust solution aimed at reducing the cost associated with long-read sequencers. ArgenTAG's platform integrates micro-fabrication, next-generation DNA sequencing, molecular biology, and mechanical engineering to create synthetic DNA barcodes. This innovation allows for the simultaneous sequencing of thousands of samples, enabling medical professionals to analyze antibodies and perform single-cell sequencing efficiently.

Gisens Biotech is a biotechnology company focused on bioelectronics and nanotechnology, developing portable diagnostics such as the Nano-Lab, a device that provides real-time measurements of biomarkers from tiny samples of blood, urine, or saliva. The Nano-Lab aims to deliver accurate, portable biomarker analysis and interpretation, potentially changing how measurements are performed. The company is also pursuing a nanotechnology-based platform to diagnose and monitor renal biomarkers—urea, creatinine, and potassium—from a single blood drop, with results accessible through an application for real-time health monitoring.

CASPR Biotech is a San Francisco-based company established in 2018 that specializes in the development of a CRISPR-based platform for diagnosing antimicrobial resistances (AMR) and infectious diseases. The company focuses on creating portable diagnostic kits that utilize proprietary CRISPR Cas enzymes to detect specific DNA and RNA sequences, as well as signature amino acid sequences associated with infectious diseases and genetic mutations. These kits are designed to provide clinicians with a simple, fast, and affordable solution for molecular detection, enhancing the efficiency of disease identification in clinical and hospital settings.

Bioplaster Research is a biomaterial company dedicated to developing sustainable alternatives to petroleum-based plastics. It focuses on creating innovative technologies and materials from regenerative resources, aiming to mitigate environmental harm and foster a greener future. The company's mission is to address current and emerging environmental challenges by leveraging nanotechnology and other scientific advancements.

Fecundis is a company based in Rosario, Argentina, specializing in reproductive biology. It develops innovative solutions aimed at improving sperm competence and enhancing the success rates of assisted reproductive technologies. By utilizing advanced technology grounded in scientific research, Fecundis focuses on increasing sperm functionality and generating higher quality embryos, ultimately enabling patients to achieve successful pregnancies through fertility treatments.

Michroma is a biotech company that develops natural, thermostable colorants for fungus-based food and cosmetics by leveraging fermentation of filamentous fungi and synthetic biology. It aims to replace synthetic pigments with natural pigments produced through biotechnological fermentation, delivering pH- and heat-stable colorants at scale for food and cosmetic applications. The company operates in multiple locations, including San Francisco, United States, and Rosario, Argentina, and pursues scalable production in bioreactors using proprietary fungal strains.

Hiamet S.A. is a biotechnology company based in Santa Fe, Argentina, specializing in the development and manufacture of additives for biogas production. The company offers a range of services, including process design, development, analysis, and scaling up of biotechnological solutions aimed at addressing challenges in bioenergy and environmental impact. Hiamet focuses on creating effective methods and additives for converting organic waste into energy, contributing to sustainable energy solutions.

Syocin Biotech is an Argentina-based company dedicated to advancing agricultural biotechnology through a synthetic biology platform. The company specializes in redesigning natural biomolecules to create precision bactericidal proteins aimed at targeting plant bacterial pathogens that jeopardize global food security. By developing innovative biobactericides, Syocin Biotech enables efficient and sustainable solutions for combating crop pathogens, contributing to enhanced agricultural productivity and food availability.

Microgenesis is a biotechnology company focused on fertility and pregnancy health monitoring. It has developed a platform that provides a non-invasive fertility test and personalized nutritional supplementation aimed at restoring women's fertility potential. The company's innovative diagnostic approach detects subclinical inflammation that negatively impacts ovarian function and implantation, specifically targeting women who have experienced challenges, including multiple failed IVF attempts. Operating out of a CLIA lab in Oakland, Microgenesis offers its solutions through OB-GYNs and direct-to-consumer channels. Additionally, the platform addresses imbalances in vaginal and intestinal microbiota linked to infertility and offers dual testing for immunological issues related to the endometrium, equipping patients with effective treatment options for complex reproductive health cases.

Einsted is a biotechnology company based in Argentina, focused on optimizing bioindustrial processes through its innovative BioElectroProcessor technology. This advanced electrochemical system applies electrical pulses to induce NanoPulsed Reactions, facilitating the development of new starches and enhancing their production efficiency. By leveraging this technology, Einsted aims to provide sustainable solutions for the Food, Pharma, and Cosmetic industries, enabling them to reduce reliance on harmful and hazardous chemicals in their manufacturing processes. The company's mission centers on promoting health and environmental protection through its cutting-edge biotechnology solutions.

Tomorrow Foods is a company based in Pergamino, Argentina, specializing in the development and production of plant-based ingredients and additives for the food industry. Its offerings include solutions for various applications such as sports nutrition, meat extenders, pasta, dressings, soups, sauces, snacks, cereals, functional beverages, dairy substitutes, and baked goods. By providing integrated turnkey solutions, Tomorrow Foods enables clients to launch nutritious and sustainable products efficiently. The company focuses on introducing innovative alternatives that promote a diverse and well-rounded diet, aligning with the growing consumer demand for healthier food options. Through its research and development efforts, Tomorrow Foods aims to contribute to the evolution of food towards more sustainable practices.

Stämm Biotech is a San Francisco-based company specializing in advanced bioproduction systems designed to address the scaling challenges in the biotech industry. Founded in 2014, Stämm has developed an innovative biomanufacturing solution that integrates microfluidics, electroporation, and robotics, resulting in a compact, all-in-one Bioprocessor. This system has demonstrated productivity levels at least 70 times greater than traditional bioreactors, enabling clients to miniaturize bioreactors and optimize conditions more efficiently. Stämm's technology incorporates various sensors to monitor biological, physical, and chemical variations throughout the bioprocess, facilitating a streamlined approach to microbial growth and monoclonal cell line development. By transforming large-scale biotech operations into a more manageable micro-factory network, Stämm aims to unlock significant market potential in the coming years.

Radial Biomateriales, established in 2018 and headquartered in Zapopan, Mexico, specializes in the production of biodegradable packaging and related products. The company innovatively utilizes agro-industrial waste to create these eco-friendly solutions, targeting applications in packaging, industrial design, and interior design.

Enteria is a biotechnology research company focused on providing microbiota analysis services tailored specifically for women. Operating under a business-to-business model, the company specializes in intestinal microbiota analysis, which serves as a valuable tool for healthcare professionals in diagnosing and treating patients. Enteria collaborates with research centers and private companies to deliver customized services, enhancing the capabilities of healthcare providers and enabling them to offer superior patient care. Through its innovative approach, Enteria aims to advance the understanding of microbiota and its implications for health.

Aplife Biotech is an Argentine biotechnology startup founded in 2018, based in Buenos Aires. The company focuses on developing innovative technologies for the high-throughput discovery of novel aptamers, which are synthetic DNA-derived molecules used in biosensors. Aplife Biotech's platform enables the manufacture of large combinatorial libraries of these aptamers in predefined locations, facilitating the mass screening of important biological molecules. This technology addresses global challenges in medical diagnostics by supporting the creation of novel biosensors and diagnostic assays, as well as therapeutic applications.

CASPR Biotech is a San Francisco-based company established in 2018 that specializes in the development of a CRISPR-based platform for diagnosing antimicrobial resistances (AMR) and infectious diseases. The company focuses on creating portable diagnostic kits that utilize proprietary CRISPR Cas enzymes to detect specific DNA and RNA sequences, as well as signature amino acid sequences associated with infectious diseases and genetic mutations. These kits are designed to provide clinicians with a simple, fast, and affordable solution for molecular detection, enhancing the efficiency of disease identification in clinical and hospital settings.

Bitgenia is a genomic analysis company based in Ciudad Autonoma de Buenos Aires, Argentina, founded in 2015. The company specializes in developing advanced software tools designed to convert genomic data into actionable insights. Its primary product, the B-Platform, enables the analysis and interpretation of data generated by next-generation sequencing technologies, including gene panels, exomes, and whole genomes. Bitgenia also offers customized software solutions for the storage and analysis of genomic data, along with training and support services. With a mission to enhance lives through accessible genomic information, Bitgenia focuses on providing genetic testing that impacts health, nutrition, and physical activity, particularly in Latin America. The platform leverages artificial intelligence to securely share relevant DNA variants, empowering users to make informed decisions regarding their health and well-being.

Zev Biotech is an Argentine biotechnology company focused on the study of DNA for clinical diagnostic applications. It has developed a novel platform for molecular diagnostics, allowing for the production of customized diagnostic kits tailored to hereditary and infectious diseases, as well as pharmacogenomics. By leveraging proprietary technologies that integrate reagents, equipment, and software based on microarray techniques, Zev Biotech aims to enhance the accuracy of genetic and infectious disease diagnoses, providing accessible molecular biology diagnostics to healthcare professionals.

MZP Tech is a medical device company focused on point-of-care coagulation analysis. It develops diagnostic methodologies in hemostasis to support the management of bleeding and thrombotic risk. The company’s coagulation diagnostic device analyzes a small blood sample in minutes using a disposable micro-machined chip and a portable sensing system that measures blood viscosity, enabling early screening for cardiovascular-related diseases and clotting disorders.

Feedvax is an innovative company based in Argentina, established in 2018, focused on developing a platform for oral vaccines aimed at improving animal health in aquaculture. Its primary product is an oral vaccine designed to protect farmed tilapia from streptococcosis, a common disease affecting this widely farmed species. Feedvax's platform not only delivers vaccines but also provides a smart feeder that ensures nutritional and health treatments are administered automatically and individually to each animal. The company's solution is environmentally safe, cost-effective, and easy for farmers to use, promoting greater efficiency in animal production while helping to eliminate the need for antibiotics and reducing stress on the fish. By transforming traditional aquaculture practices, Feedvax aims to make a sustainable impact on the industry.

Cell Farm is a pioneering clean meat startup based in Latin America, focused on developing and standardizing biotechnological processes to produce meat from animal stem cells. By cultivating meat from these cells instead of raising animals, Cell Farm aims to provide a sustainable alternative that addresses environmental concerns, promotes consumer health, and adheres to ethical standards. The company plays a significant role in transforming the food system, contributing to a more sustainable future for humanity.

Algaebio+ is a company based in Argentina that specializes in the production of natural astaxanthin, a powerful antioxidant derived from the microalga Haematococcus pluvialis. This product is designed to offer a range of health benefits, including immunoregulatory, anti-inflammatory, and photo-protective properties, as well as potential applications in anti-aging and cancer prevention. Algaebio+ cultivates astaxanthin under controlled laboratory conditions before transitioning the production to photobioreactors. The company's offerings target various industries, including pharmaceuticals, nutraceuticals, functional foods, and cosmetics, where they aim to replace artificial pigments with their natural product. Additionally, astaxanthin is known to support joint, muscle, vision, and heart health, contributing to more effective treatments for chronic diseases.

ALYTIX Biotech develops bacteriophage-based solutions to prevent and treat bacterial infections in human and animal health. It focuses on antibiotic alternatives, offering screening, identification, characterization, formulation, and validation of bacteriophage-based approaches to address antibiotic resistance. The company aims to improve livestock health, reduce unnecessary antibiotic use, and promote environmental sustainability by providing novel methods to combat infections and enabling pharmaceutical partners to develop new treatments. Based in Santa Fe, Argentina.

Aplife Biotech is an Argentine biotechnology startup founded in 2018, based in Buenos Aires. The company focuses on developing innovative technologies for the high-throughput discovery of novel aptamers, which are synthetic DNA-derived molecules used in biosensors. Aplife Biotech's platform enables the manufacture of large combinatorial libraries of these aptamers in predefined locations, facilitating the mass screening of important biological molecules. This technology addresses global challenges in medical diagnostics by supporting the creation of novel biosensors and diagnostic assays, as well as therapeutic applications.

Beeflow S.A., founded in 2016 and based in Buenos Aires, Argentina, specializes in professional pollination services that leverage scientific knowledge and technology to enhance bee health and efficiency. The company develops organic compounds that improve the immune systems of bees and train them to pollinate specific crops, such as blueberries, almonds, raspberries, and kiwifruit. By providing these specialized pollination services, Beeflow enables farmers to significantly increase crop yields, with reported improvements ranging from 20% to 90%, while simultaneously addressing the decline in bee populations. Through its innovative approach, Beeflow aims to support agricultural productivity and ecosystem sustainability.

Stämm Biotech is a San Francisco-based company specializing in advanced bioproduction systems designed to address the scaling challenges in the biotech industry. Founded in 2014, Stämm has developed an innovative biomanufacturing solution that integrates microfluidics, electroporation, and robotics, resulting in a compact, all-in-one Bioprocessor. This system has demonstrated productivity levels at least 70 times greater than traditional bioreactors, enabling clients to miniaturize bioreactors and optimize conditions more efficiently. Stämm's technology incorporates various sensors to monitor biological, physical, and chemical variations throughout the bioprocess, facilitating a streamlined approach to microbial growth and monoclonal cell line development. By transforming large-scale biotech operations into a more manageable micro-factory network, Stämm aims to unlock significant market potential in the coming years.

Bioplaster Research is a biomaterial company dedicated to developing sustainable alternatives to petroleum-based plastics. It focuses on creating innovative technologies and materials from regenerative resources, aiming to mitigate environmental harm and foster a greener future. The company's mission is to address current and emerging environmental challenges by leveraging nanotechnology and other scientific advancements.